On September 10, 2025 Aktis Oncology, Inc., a clinical-stage oncology company focused on unlocking the breakthrough potential of targeted radiopharmaceuticals for patient populations not addressed by existing platform technologies, reported that Matthew Roden, PhD, President and Chief Executive Officer, and other members of the Aktis Oncology leadership team, will participate in the following September investor conferences (Press release, Aktis Oncology, SEP 10, 2025, View Source [SID1234655929]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Oppenheimer 3rd Annual Targeted Radiopharmaceutical Therapies in Oncology Summit

Date:

Thursday, September 11, 2025

Location:

New York, N.Y.

Bank of America Healthcare Trailblazers Private Company Conference

Date:

Wednesday, September 17, 2025

Location:

Everett, Mass.